Bystander CD8

Authors :: Yannick, Simoni
Etienne, Becht
Michael, Fehlings
Chiew Yee, Loh
Si-Lin, Koo
Karen Wei Weng, Teng
Joe Poh Sheng, Yeong
Rahul, Nahar
Tong, Zhang
Hassen, Kared
Kaibo, Duan
Nicholas, Ang
Michael, Poidinger
Yin Yeng, Lee
Anis, Larbi
Alexis J, Khng
Emile, Tan
Cherylin, Fu
Ronnie, Mathew
Melissa, Teo
Wan Teck, Lim
Chee Keong, Toh
Boon-Hean, Ong
Tina, Koh
Axel M, Hillmer
Angela, Takano
Tony Kiat Hon, Lim
Eng Huat, Tan
Weiwei, Zhai
Daniel S W, Tan
Iain Beehuat, Tan
Evan W, Newell
Source :: Nature. 557(7706)
Publication Year :: 2017
Abstract: Various forms of immunotherapy, such as checkpoint blockade immunotherapy, are proving to be effective at restoring T cell-mediated immune responses that can lead to marked and sustained clinical responses, but only in some patients and cancer types

Subjects :: ErbB Receptors
Lung Neoplasms
Lymphocytes, Tumor-Infiltrating
Phenotype
Antigens, Neoplasm
Apyrase
Humans
Bystander Effect
Cell Separation
CD8-Positive T-Lymphocytes
Colorectal Neoplasms
Antigens, Viral

Tools